These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 3252243)

  • 1. The relative contribution of ascending and descending serotonergic pathways in p-chloroamphetamine-induced antinociception.
    Bjørkum AA; Berge OG
    Pharmacol Biochem Behav; 1988 Sep; 31(1):135-40. PubMed ID: 3252243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lesions of the ascending serotonergic pathways and antinociceptive effects after systemic administration of p-chloroamphetamine in mice.
    Hunskaar S; Berge OG; Broch OJ; Hole K
    Pharmacol Biochem Behav; 1986 Mar; 24(3):709-14. PubMed ID: 3703904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of spinal serotonergic pathways in nociception but not in avoidance learning.
    Ogren SO; Berge OG; Johansson C
    Psychopharmacology (Berl); 1985; 87(3):260-5. PubMed ID: 3001802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective lesions of the bulbospinal serotonergic pathways reduce the analgesia induced by p-chloroamphetamine in the hot-plate test.
    Berge OG; Ogren SO
    Neurosci Lett; 1984 Jan; 44(1):25-9. PubMed ID: 6717848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective neurotoxic lesions of descending serotonergic and noradrenergic pathways in the rat.
    Berge OG; Fasmer OB; Tveiten L; Hole K
    J Neurochem; 1985 Apr; 44(4):1156-61. PubMed ID: 3919157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of central serotonergic pathways in nefopam-induced antinociception.
    Hunskaar S; Fasmer OB; Broch OJ; Hole K
    Eur J Pharmacol; 1987 Jun; 138(1):77-82. PubMed ID: 2442003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-HT depletion with 5,7-DHT, PCA and PCPA in mice: differential effects on the sensitivity to 5-MeODMT, 8-OH-DPAT and 5-HTP as measured by two nociceptive tests.
    Eide PK; Hole K; Berge OG; Broch OJ
    Brain Res; 1988 Feb; 440(1):42-52. PubMed ID: 2965956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time course of changes in nociception after 5,6-dihydroxytryptamine lesions of descending 5-HT pathways.
    Berge OG; Fasmer OB; Flatmark T; Hole K
    Pharmacol Biochem Behav; 1983 Apr; 18(4):637-43. PubMed ID: 6867068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Test-dependent antinociceptive effect of spinal serotonin release induced by intrathecal p-chloroamphetamine in mice.
    Berge OG; Fasmer OB; Jørgensen HA; Hole K
    Acta Physiol Scand; 1985 Jan; 123(1):35-41. PubMed ID: 3155890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endogenously produced 5,6-dihydroxytryptamine may mediate the neurotoxic effects of para-chloroamphetamine.
    Commins DL; Axt KJ; Vosmer G; Seiden LS
    Brain Res; 1987 Sep; 419(1-2):253-61. PubMed ID: 2445423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Forebrain serotonin and avoidance learning: behavioural and biochemical studies on the acute effect of p-chloroamphetamine on one-way active avoidance learning in the male rat.
    Ogren SO
    Pharmacol Biochem Behav; 1982 Jun; 16(6):881-95. PubMed ID: 7111347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Test-dependent variations in the antinociceptive effect of p-chloroamphetamine-induced release of 5-hydroxytryptamine.
    Ogren SO; Berge OG
    Neuropharmacology; 1984 Aug; 23(8):915-24. PubMed ID: 6237274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of p-chloroamphetamine and 5,7-dihydroxytryptamine on rotation and dopamine turnover.
    Giambalvo CT; Snodgrass SR
    Brain Res; 1978 Jun; 149(2):453-67. PubMed ID: 566608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for selective serotonergic receptor involvement in p-chloroamphetamine-induced antinociception.
    Ogren SO; Berge OG
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Apr; 329(2):135-40. PubMed ID: 4010792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic cannabinoids produce CB₁-mediated antinociception by activation of descending serotonergic pathways that act upon spinal 5-HT(7) and 5-HT(2A) receptors.
    Seyrek M; Kahraman S; Deveci MS; Yesilyurt O; Dogrul A
    Eur J Pharmacol; 2010 Dec; 649(1-3):183-94. PubMed ID: 20868676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-HT loss in rat brain following 3,4-methylenedioxymethamphetamine (MDMA), p-chloroamphetamine and fenfluramine administration and effects of chlormethiazole and dizocilpine.
    Colado MI; Murray TK; Green AR
    Br J Pharmacol; 1993 Mar; 108(3):583-9. PubMed ID: 7682129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p-Chloroamphetamine releases both serotonin and dopamine into rat brain dialysates in vivo.
    Sharp T; Zetterström T; Christmanson L; Ungerstedt U
    Neurosci Lett; 1986 Dec; 72(3):320-4. PubMed ID: 3822235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for dual serotonergic projections to neocortex: axons from the dorsal and median raphe nuclei are differentially vulnerable to the neurotoxin p-chloroamphetamine (PCA).
    Mamounas LA; Molliver ME
    Exp Neurol; 1988 Oct; 102(1):23-36. PubMed ID: 2846339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The serotonergic antidepressant nefazodone inhibits the serotonin transporter: in vivo and ex vivo studies.
    Owens MJ; Ieni JR; Knight DL; Winders K; Nemeroff CB
    Life Sci; 1995; 57(24):PL373-80. PubMed ID: 7475971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of orphenadrine-induced antinociception in mice: a role for serotonergic pathways.
    Hunskaar S; Rosland JH; Hole K
    Eur J Pharmacol; 1989 Jan; 160(1):83-91. PubMed ID: 2469592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.